IART · Integra Lifesciences Holdings Corp
United States · RS rating 31 · As of 2026-10-14
| Price | 13.18 USD |
|---|---|
| 1-day change | -4.9% |
| RS rating (overall / 1M / 3M / 12M) | 31 / 15 / 10 / 39 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 33 / 24 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | +68.9% |
| Sales growth Q/Q | +8.2% |
| Distance from 52-week high | +33.6% |
| Market cap (USD) | $804.3M |